HOW WE FEEL ABOUT ANALYTICS

WHO WE ARE 

We are trained optimizers and data scientists specializing in quantitative finance, applied analytics, and robust optimization. 

We are a data science and technology company headquartered in Boston, MA. Founded in 2012 by a group of Ph.D.’s, the MIT-trained team combines world-class technical knowledge and practical experience. 

We have extensive industry experience and unique backgrounds at the intersection of analytics, heathcare and software development. Our co-founder was a key contributor to a market-leading healthcare analytics tool, D2Hawkeye (sold to Verisk Health 2009). 

We have a proven track record of building, managing, and commercializing products driven by sophisticated prescriptive analytics applied to health plan decision making and management. BST combines world-class technical knowledge and practical financial experience. BST is unique in the market in that it’s the only solution of its kind that describes what has occurred, predicts what’s likely to occur next and prescript specific action based on that data.) 

  • BST is a privately-owned company 

  • Headquartered in Boston, MA.  Offices in Atlanta and Houston.

  • All client data is housed, managed and maintained on-shore.  

  • SOC1, SOC2 with HITRUST, SSAE-18 and HIPAA compliant

OUR TEAM

Board Members 

Dimitris Bertsimas, Ph.D.

Sid Mann

Yiannis Monvoukas, Ph.D., MBA

Clyde Parker, J.D.

Stephen Sofoul, MBA

Leadership

Stephen Sofoul, MBA – CEO & President

Sid Mann – Vice President

Dimitris Bertsimas, Ph.D.  – Chief Scientist

Neil Larson – Chief Strategy Officer

Yankang Jiang – Chief Technology Officer

Marc Kutter – Director of Sales​

Bryan Hawkins – Director of Account Management

Dimitris Bertsimas, Ph.D.
Ph.D.  Co-Founder, Chief Scientist

Dr. Bertsimas is currently the Boeing Professor of Operations Research and the co-director of the Operations Research Center and faculty director of the Master of Business analytics at MIT. He received his SM and PhD in Applied Mathematics and Operations Research from MIT in 1987 and 1988 respectively. He has been with the MIT faculty since 1988. His research interests include optimization, machine learning and applied probability and their applications in health care, finance, operations management, and transportation. He has co-authored more than 220 scientific papers and four graduate-level textbooks. He is the editor in Chief of INFORMS Journal of Optimization and former department editor in Optimization for Management Science and in Financial Engineering in Operations Research. He has supervised 62 doctoral students and he is currently supervising 25 others. He is a member of the National Academy of Engineering since 2005, an INFORMS fellow, and he has received numerous research awards including the Morse prize (2013), the Pierskalla award for best paper in health care (2013), the best paper award in Transportation (2013) the Farkas prize (2008), the Erlang prize (1996), the SIAM prize in optimization (1996), the Bodossaki prize (1998) and the Presidential Young Investigator award (1991-1996)

 

In early 2000 Dr. Bertsimas co-founded D2Hawkeye, a market-leading healthcare analytics tool (sold to Verisk in 2009).  Benefits Science Technologies (BST) was launched from the campus of MIT in 2012.  Dr. Bertsimas is recognized as an early pioneer in healthcare analytics since 2001 and has led advancing technologies in data science, robust optimization and Ai to optimizes some of the world’s most complex systems.

Sid Mann
Co-Founder, Vice-President

Mr. Mann is the co-founder of Benefits Science and serves as the Vice-President of the company. He previously served as the Vice-President of PeopleManage Pro, a leading healthcare consulting firm based in The Woodlands, TX. Mr. Mann has extensive experience building and managing sales organizations in multiple industries. His previous experience includes serving as the President of a heavy equipment manufacturing firm based in Houston, TX as well as a managing partner of a financial consulting firm based in The Woodlands, TX. Mr. Mann began his career as a sales manager with AT&T in Sandy, UT and received his B.S. in Finance from Brigham Young University. Mr. Mann resides in Conroe, TX and holds a life & health insurance license.

Board Member
Yiannis A. Monovoukas, Ph.D.

Yiannis Monovoukas, Ph.D., MBA, is a member of the Board of Directors of Benefits Science Technologies.  He is the former Chairman, President, and CEO, and major shareholder of TEI Biosciences Inc. and TEI Medical Inc., two regenerative medicine companies based on technology generated at MIT focusing on the repair, reinforcement, and regeneration of soft tissues.  Both companies were sold to Integra LifeSciences in 2015. Dr. Monovoukas is also the Founder, President, and CEO of Helios Cardiovascular and Helios Biomedical, and the co-Founder, President, and CEO of AuraGen Aesthetics and Quantum Medical Analytics.

Prior to joining TEI, he was President and CEO of Thermo Fibergen, a Thermo Electron (now Thermo Fisher Scientific) spin out, which he grew from an R&D concept to a profitable public company.  Dr. Monovoukas holds a BS degree from Columbia University and MS and Ph.D. degrees from Stanford University, all in chemical engineering, as well as an MBA from the Harvard Business School.  Dr. Monovoukas was the winner of the prestigious Ernst & Young Entrepreneur Of The Year® 2011 Award for New England in Life Sciences and was a 2011 Life Sciences US National Finalist.  The program recognizes global entrepreneurs who demonstrate excellence and extraordinary success.  He also served on a panel of judges for 2012, 2013 and 2014 E&Y Entrepreneur of the Year® New England Awards Program, and on the 2015 and 2016 US national judging panel for life sciences.  TEI was also the winner of the SBANE 2011 New England Innovation Award.

 

Since 2010, Dr. Monovoukas has been serving on the Board of Directors of Owlstone, a leading-edge nanotechnology chemical sensing company span out of the University of Cambridge, England, focusing on the early detection of cancer and inflammatory diseases via highly selective identification of biomarkers in breath and bodily fluids.  From 2011 to 2014, he served as a Mentor for the Columbia Engineering Entrepreneurship Program, and as of 2015, he is serving as a member of the Board of Overseers of the Boston Museum of Science.  Dr. Monovoukas was recently elected to serve on the Board of Directors of InterAx Biotech AG, a Swiss biopharmaceutical company focusing on the discovery of novel and safer GPCR drugs.

Clyde Parker, J.D.
Board Member

Clyde Parker is a member of the Board of Directors of Benefits Science Technologies. Clyde is an attorney with Winstead who has deep experience and expertise, which includes mergers and acquisitions, public offerings of debt and equity securities, capital formation transactions involving venture capital financings, seller financings, private placements, and corporate counseling to public and private companies on various corporate and securities matters.  Clyde’s experience also spans securities law compliance and filings, including Sarbanes-Oxley, corporate governance and antitakeover issues.  His clients have included energy and energy services companies, manufacturing companies and technology companies as well as venture funds and individual investors. Earlier in his professional career he practiced as a certified public accountant for nine years.

Stephen Sofoul
Co-Founder, President 

Mr. Sofoul is the co-founder of Benefits Science and serves as the CEO & President of the company. He previously served as the President of a specialized healthcare consulting firm based in The Woodlands, TX. In addition to his experience as a start-up specialist, Mr. Sofoul has led organizations in both the manufacturing and services sectors. His previous experience includes serving as the Vice-President of a heavy equipment manufacturing firm based in Houston, TX as well as managing director of a financial consulting firm based in The Woodlands, TX. Mr. Sofoul received his B.S. in Finance and received an M.B.A. from the Massachusetts Institute of Technology (MIT). Mr. Sofoul resides in Boston, MA and holds a life & health insurance license, life & health insurance counselor license, GBA (Group Benefits Associate) designation. 

Neil Larson
Chief Strategy Officer

Mr. Larson serves as the Chief Strategy Officer for the company. He previously served as a credentialed actuary for Aon Hewitt and Gallagher (2 of the 4 largest insurance consulting firms in the world), where he worked on numerous Fortune 500 and Global 500 partner accounts.  Mr. Larson led in-house domestic benefits for a global 500 production firm, with strong financial results.  He carries specialties including: actuarial projections, cost reduction strategies, accounting and budgeting forecasts, claims analysis, data warehousing, health insurance reform, liability reserving, provider discount analysis and employee contributions.  Mr. Larson earned a B.A. in economics from Brigham Young University (BYU) and holds a life & health insurance license.  He and his family reside in Boston, MA. 

Board Member
Yiannis A. Monovoukas, Ph.D.

Yiannis Monovoukas, Ph.D., MBA, is a member of the Board of Directors of Benefits Science Technologies.  He is the former Chairman, President, and CEO, and major shareholder of TEI Biosciences Inc. and TEI Medical Inc., two regenerative medicine companies based on technology generated at MIT focusing on the repair, reinforcement, and regeneration of soft tissues.  Both companies were sold to Integra LifeSciences in 2015. Dr. Monovoukas is also the Founder, President, and CEO of Helios Cardiovascular and Helios Biomedical, and the co-Founder, President, and CEO of AuraGen Aesthetics and Quantum Medical Analytics.

Prior to joining TEI, he was President and CEO of Thermo Fibergen, a Thermo Electron (now Thermo Fisher Scientific) spin out, which he grew from an R&D concept to a profitable public company.  Dr. Monovoukas holds a BS degree from Columbia University and MS and Ph.D. degrees from Stanford University, all in chemical engineering, as well as an MBA from the Harvard Business School.  Dr. Monovoukas was the winner of the prestigious Ernst & Young Entrepreneur Of The Year® 2011 Award for New England in Life Sciences and was a 2011 Life Sciences US National Finalist.  The program recognizes global entrepreneurs who demonstrate excellence and extraordinary success.  He also served on a panel of judges for 2012, 2013 and 2014 E&Y Entrepreneur of the Year® New England Awards Program, and on the 2015 and 2016 US national judging panel for life sciences.  TEI was also the winner of the SBANE 2011 New England Innovation Award.

 

Since 2010, Dr. Monovoukas has been serving on the Board of Directors of Owlstone, a leading-edge nanotechnology chemical sensing company span out of the University of Cambridge, England, focusing on the early detection of cancer and inflammatory diseases via highly selective identification of biomarkers in breath and bodily fluids.  From 2011 to 2014, he served as a Mentor for the Columbia Engineering Entrepreneurship Program, and as of 2015, he is serving as a member of the Board of Overseers of the Boston Museum of Science.  Dr. Monovoukas was recently elected to serve on the Board of Directors of InterAx Biotech AG, a Swiss biopharmaceutical company focusing on the discovery of novel and safer GPCR drugs.

Omid Nohadani
Data Science Lead

Mr. Nohadani is an optimization and machine learning scientist with proven track record of developing algorithms and solutions for big-data environments affected by uncertainty and subjected to complex risk measures, including chemoradiotherapy, pharmaceutical networks, and satellite systems.  Successfully led and fundraised interdisciplinary projects both in established industries and in emerging technologies with the goal of integrating novel theory and real-world implementation, e.g., in healthcare, supply chain management, robust analytics, and cyber-physical systems.  Extensive modeling, programming, and high-performance computing experience. Effective mentorship of undergraduate and PhD students, leading to academic, government, and industry careers (e.g., MIT, NASA, Apple).

Michael Morrow
Chief Actuary

In his senior management role, Michael Morrow brings an actuarial perspective to the company’s healthcare analytics platform and provides counsel on the actuarial implications of business strategies and regulatory changes. Working with the Data Science team, he applies his more than 20 years of financial and quantitative analysis, product development, and consulting expertise to identify key areas of risk and cost in order to create customized solutions to improve client health plans.  Michael earned his MBA degree from the University of Denver, CO. He received his B.S. in Actuarial Science, graduating with honors from Drake University, Iowa.  He is a Fellow with the Society of Actuaries and a member of the American Academy of Actuaries.  Michael and his family currently reside in Denver Colorado.

Yankang Jiang
Chief Technology Officer

Yankang Jiang, Chief Technology Officer, leads BST's long-term technology version, is responsible for platform architecture and development, and managing the engineering division.

Prior to joining BST, he served as Chief Technology Officer of Cignifi, where he led the team to launch the credit risk platform using alternative data. He joined Cignifi from Dazzling Intelligence, where he was a founder.   He started his career in 2011 as a founding member and Vice President of Technology at Adelphic, which was backed up by Google Venture and acquired by Times Inc. In Adelphic, he led the team to build a leading real-time bidding advertising platform.   Yankang has a Master of Science in electrical engineering from Shanghai University and Bachelor of Science in electrical engineering from Zhejiang University.

Marc D. Kutter
Partner, Director of Sales

Mr. Kutter is responsible for strategic distribution relationships and leads national sales efforts. He has led companies in employee benefits, financial services, and healthcare industries as an executive in various strategy, business development, and operational roles ranging in size from early stage start-ups to large corporations.  In addition, Mr. Kutter proudly served as an Infantry Officer in the United States Army, serving in the 10th Mountain Division and the 82nd Airborne Division in the Middle East, Central America, and the Balkans. Marc earned his Bachelor of Science degree from the United States Military Academy at West Point, New York.  Marc also serves on several boards for early stage companies mentoring entrepreneurs and giving back to the community by working with several non-profit organizations.

Bryan Hawkins
Director of Account Management

Mr. Hawkins is responsible for client care data management coordination. He works closely with the client TPA’s to facilitate the data transfer and project analysis. Prior to joining Benefits Science, Mr. Hawkins spent 7 years with Wells Fargo as a Loan Consultant. Mr. Hawkins received a B.S. from Baylor University in Finance and Quantitative Business Analysis and was a scholarship member of the Baylor University Football Team.